Biocon to fully integrate Biologics unit in $5.5 bn deal
Bengaluru, Dec 6 (IANS) Biopharmaceuticals company Biocon on Saturday announced to fully integrate its biosimilar unit Biocon Biologics as a wholly owned subsidiary in a $5.5 billion deal. The company, in a statement, noted that it will acquire the remaining stake in Biocon Biologics from Serum Institute Life Sciences, Tata Capital Growth Fund II, and […]
